[1]
T. Kadhim Mohammed and B. . Shihab Ahmed, “The Association between Immune-Histochemical Expressions of Program death ligand with Some Aggressive Features of Prostate Cancer”, Al-Nahrain J. Sci., vol. 27, no. 2, pp. 63–67, Jun. 2024, doi: 10.22401/g18c0m59.